97 SAMHSA-listed treatment centers in Montana. Free, confidential help available 24/7.
Browse 97 verified drug and alcohol treatment facilities in Montana. Each listing is sourced from federal databases and verified for accuracy. Use the information below to compare programs, verify insurance acceptance, and find the right facility for your needs.
Need help choosing? Call for free, confidential guidance from a treatment specialist.
Montana ranks at 32.6 drug overdose deaths per 100,000 residents per the most recent CDC WONDER data — at the national rate of 32.6/100k. Of the verified treatment facilities listed here, roughly 70-80% offer outpatient programs, 20-25% provide medical detox or residential rehabilitation, and a smaller subset addresses dual-diagnosis cases.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
The first 90 days after leaving treatment carry roughly 60% of total post-treatment relapse risk in Montana. The mitigation is structured aftercare — outpatient therapy, sober living, mutual-support, MAT if applicable, peer recovery.
After PHP or IOP, most Montana programs step patients down to weekly individual therapy + monthly med management for 6–12 months.
Sober living houses provide drug-free transitional housing with peer accountability. NARR-certified residences in Montana are the safest bet — verify before signing.
The mutual-support landscape in Montana includes 12-step (AA/NA), cognitive (SMART Recovery), Buddhist (Refuge), and secular (LifeRing) options. Online meetings extend access.
MAT is a chronic-disease management strategy, not a short-term bridge. Montana patients on long-term MAT show materially lower relapse and overdose rates.
Peer Recovery Specialists are people in stable recovery, certified by Montana, who help others navigate the post-treatment landscape — employment, housing, court, parenting.
Standing-order naloxone access throughout Montana pharmacies. Get a kit; train your support network on intramuscular or intranasal administration; refresh annually.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
Whether you choose a non-profit IOP in your hometown or a private residential program elsewhere in Montana, hours-per-day, group-therapy density, and medical-management cadence follow industry-standard patterns. The card grid below outlines the standard modalities.
Evidence-based for alcohol, cannabis, cocaine, and methamphetamine use disorders. Typically 12–24 sessions; manualized protocols available for clinicians.
For ambivalent patients, MI outperforms didactic education. The clinician evokes rather than installs reasons for change.
For alcohol-use disorder: naltrexone (oral or injection), acamprosate, or disulfiram. For opioid use disorder: buprenorphine, methadone, or naltrexone.
Adapted from BPD treatment, DBT-SUD (substance use disorders) is a standard offering at many mid-size addiction programs in Montana.
Combat veterans, survivors of childhood adversity, and trauma-affected patients benefit from integrated trauma-focused work alongside substance-use therapy.
Most Montana programs expose patients to multiple support frameworks — AA, NA, SMART Recovery, Refuge Recovery, LifeRing — rather than insisting on one.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Montana must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · Montana Medicaid · Tricare (military) · VA Community Care
In Montana, Medicaid is administered as Montana Medicaid. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
Family involvement in Montana treatment programs has moved from optional extra to core curriculum over the last 15 years. Programs that engage at least one family member during treatment have measurably lower 1-year relapse rates.
Most Montana addiction treatment programs follow a similar five-step admission process. From first call to first day in treatment, expect 1–7 days depending on facility availability and insurance verification turnaround. Same-day admissions are possible for acute cases, especially at facilities providing medical detox in major Montana metro areas.
Roughly 11–14% of Montana residents are uninsured. The good news: every state, including Montana, has multiple pathways to substance-use treatment for people without insurance. The hard part is navigating which to use; the options below cover most situations.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
Targeted programming is now table stakes at mid-size Montana facilities — generic mixed-group programming is no longer the default for veterans, adolescents, or dual-diagnosis patients.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
This section covers state-level context for addiction treatment in Montana: how the clinical continuum is structured, what federal resources are available, how insurance works in practice, and what evidence-based approaches apply to different substances and populations. The goal is to equip you to navigate Montana treatment options effectively, whether you're researching for yourself or a family member.
Montana addiction treatment operates within a federal regulatory framework set by SAMHSA, the FDA (medication approvals), the DEA (controlled-substance authority), and CMS (Medicare/Medicaid coverage rules). 42 CFR Part 2 governs the confidentiality of substance-use treatment records — stricter than HIPAA, requiring written patient consent for most disclosures. This means information about your treatment generally cannot be shared with employers, family members, or other providers without your written permission, with narrow exceptions for medical emergencies and child-abuse mandated reporting.
Cost expectations for Montana residential addiction treatment range broadly: 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 before insurance pays; premium or specialty facilities can run $30,000-$70,000+. With in-network insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
In Montana, the standard continuum of substance-use treatment recognized by state licensing authorities follows ASAM levels of care: Level 0.5 early intervention, Level 1 outpatient, Level 2 intensive outpatient / partial hospitalization, Level 3 residential / inpatient, and Level 4 medically managed intensive inpatient. Patients are placed into the level that matches their withdrawal risk, biomedical status, emotional/behavioral conditions, readiness to change, relapse potential, and recovery environment — six dimensions that, together, define clinical appropriateness rather than insurance bias.
Overdose response in Montana: signs of opioid overdose include slowed or stopped breathing, blue lips or fingertips, pinpoint pupils, unconsciousness, and limp body. If you suspect overdose: call 911 immediately, administer naloxone (Narcan nasal spray is the most common form), perform rescue breathing or CPR if trained, and stay with the person until paramedics arrive. Montana Good Samaritan laws generally protect callers from prosecution for drug-related offenses when seeking emergency help for an overdose, though specific protections vary by state.
Employment re-entry after addiction treatment is a Montana priority that intersects with insurance, housing stability, and long-term recovery. The Americans with Disabilities Act protects employees in recovery from discrimination based on past substance use (current illegal use is not protected). The Family and Medical Leave Act may apply to treatment-related absences. Montana vocational rehabilitation services offer career counseling, education funding, and job placement support for individuals whose substance use has impaired employment. Recovery-friendly employers are an emerging movement in many Montana markets.
Medication-assisted treatment (MAT) is the evidence-based standard for opioid use disorder in Montana. Three medications carry FDA approval: methadone (full opioid agonist, dispensed only at federally certified opioid treatment programs); buprenorphine (partial agonist, prescribed in office-based settings by waivered providers); and naltrexone (opioid antagonist, available as monthly injection). Multiple RCTs and meta-analyses show MAT reduces overdose death by approximately 50% versus abstinence-based approaches. NIDA, SAMHSA, ASAM, and the AMA all endorse MAT as first-line.